PP_1170x120_10-25-21

Chains are blazing a path toward health equity

Chains are blazing a path toward health equity

Good news for those paying close attention to the fight for health equity: We’re seeing a tide change in the industry. For years, many groups have been talking about the moral imperative of improving health equity, but recently there’s been increased momentum toward real, lasting change. The pandemic and the push for social justice have

Amazon’s One Medical purchase threatens pharmacies

Amazon’s One Medical purchase threatens pharmacies

Since Amazon Pharmacy launched in November 2020, the prescription drug home-delivery service has led with a primarily online offering. Its value propositions — technology-based customer support, transparent pricing, fast shipping and an app-based interface — are compelling, but without connections to the broader health care ecosystem, organic growth has been challenging. That’s about to change.

The prescription for success needs to be updated

The prescription for success needs to be updated

We are more than two years into COVID, and the health care industry still has an “edge of your seat” feel — even as the crisis wanes, there’s an uncertainty about what will happen next. This rings especially true for retail pharmacies, which experienced pandemic highs and lows. American consumers applauded as pharmacies elevated the

Pharmacies can be at the front of a new care model

Pharmacies can be at the front of a new care model

There is a gap in our nation’s health care system. Pharmacies need to act now if they want to prove they are the right ones to fill it. One of the long-standing gaps in the American health care system is a lack of accessible, efficient and cost-effective services for individuals in need of a routine

Drug chains can ward off new digital Rx players

Drug chains can ward off new digital Rx players

The U.S. prescription drug market has reached half a trillion dollars, much of it dominated by large pharmacy service providers. But with a pie this big, it’s little wonder that new players are looking to horn in on the action — in particular “digital native” start-ups that give customers the direct consumer-centric relationship and flexible

Customers have changed, and so must retail pharmacy

Customers have changed, and so must retail pharmacy

The COVID-19 crisis has undoubtedly changed customer behavior, from how people pay to what they buy. But how has the pandemic specifically affected pharmacy customers? Kearney’s pharmacy customer survey from early fall 2020 reveals that COVID-era customers have new ways of shopping, evolving preferences for obtaining prescriptions and increased expectations of their pharmacies. As the

Amazon’s disruptive actions bring opportunities

Amazon’s disruptive actions bring opportunities

Ever since its launch as an online bookstore 25 years ago, Amazon has ignored traditional economics as it solves customer challenges in new ways — raising expectations and forcing competitors to do better in the process. Over the past few years, Amazon has ramped up the number of experiments, acquisitions and offerings across the health

Pharmacy challenges abound — so do opportunities

Pharmacy challenges abound — so do opportunities

Today’s retail pharmacies face increasing pressure from all fronts. Governments are aiming to reduce health care costs, and public sentiment is pushing the industry toward a value-based model. The use of high-cost specialty drugs is increasing dispensing complexity and shifting channel volume — at a time when disruptors like Amazon are poised to impact pricing.

Chain drug’s challenge: Make operations synergistic

Chain drug’s challenge: Make operations synergistic

At the top of an organization, the leader (CEO or president) holds a unique responsibility: making the whole of the enterprise worth more than the sum of its parts. In chain pharmacy today, this is a particular challenge that requires customer-centric innovation in order to create outsized value. Consider the “parts” that comprise most modern-day

An introduction to the coming cannabis ‘gold rush’

An introduction to the coming cannabis ‘gold rush’

Editor’s note: This is Part I of an article that ran in the 1/21/19 issue of CDR. As legal cannabis-based products continue to find their way to market, promising to redefine entire categories from health, beauty and wellness to food and beverage in their wake, most chain drug retailers are scrambling to calculate the impact

What to do about mounting transportation costs

What to do about mounting transportation costs

The high value of pharmaceutical shipments has traditionally meant that all parties in the chain drug industry were primarily concerned with quality. They needed a reliable, transparent solution. Given that shipping represented a tiny percentage of drug costs, price was a lesser concern. But recently shipping rates have increased sharply. Is there anything the industry

Envisioning America on its 250th birthday

Envisioning America on its 250th birthday

On July 4, 2026, when America marks its 250th birthday, will the nation be stable and prosperous? That is the core question behind [email protected] — a multiyear initiative launched by A.T. Kearney, in partnership with The Wall Street Journal. Muhtar Kent of Coca-Cola Co., Chip Bergh of Levi Strauss, Rhonda Vetere of Estée Lauder Cos.,

Wargaming as antidote to Trump trade policy uncertainty

Wargaming as antidote to Trump trade policy uncertainty

Staying competitive in the fast-moving chain drug store world is hard enough in the best of times. But things may be about to get even tougher. Chain drug operators with significant imports, and the corresponding consumer packaged goods partners, now face potentially significant challenges to their profitability in the form of the uncertainty and mixed-signals

Adheris Health